(Q40925402)

24 September 2017

title

Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cells (English)

1 reference

24 September 2017

1 reference

J Post

1

1 reference

24 September 2017

W C Vooijs

series ordinal

2

1 reference

24 September 2017

B J Bast

series ordinal

3

1 reference

24 September 2017

G C De Gast

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

International Journal of Cancer

24 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 September 2017

volume

83

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

571-576

1 reference

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Immunotoxins in the therapy of cancer: from bench to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

The intriguing link between modulation of both multidrug resistance and ligand-toxin conjugate cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Comparison of various in vitro assays for efficacy screening of immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

21 January 2018

Immunotoxins: an update

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Reversal of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Quantitative determination of the MDR-related P-glycoprotein, Pgp 170, by a rapid flow cytometric technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Immunotherapy of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Minimal residual disease as the target for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819991112%2983%3A4%3C571%3A%3AAID-IJC21%3E3.0.CO%3B2-N

10.1002/(SICI)1097-0215(19991112)83:4<571::AID-IJC21>3.0.CO;2-N

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference